Labiotech.eu

News and Trends 20 Feb 2020

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

The German biotech Immatics will partner with GSK and could receive more than €1B from the big pharma for developing cancer immunotherapies based on engineered immune T-cells. Immatics will collaborate with GSK to develop two T-cell therapies that express a protein engineered to detect cancer antigens and kill cancer cells. In return, Immatics will receive […]

February 20, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 19 Feb 2020

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which is designed to reduce the costs of viral vector production for gene therapies. The investment comes from Gamma Biosciences, an investment platform supported by the US investor KKR. Gamma Biosciences aims to acquire and invest in businesses developing gene and […]

February 19, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 18 Feb 2020

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

Belgian biotech OncoDNA has raised €19M in Series B funding to further develop its cancer diagnostic and therapeutic decision-making software. The funding was led by Vesalius Biocapital, a Luxembourg-based VC investor, Swiss VC firm Swisscanto Invest by Zürcher Kantonalbank, and Belgian VC company SFPI-FPIM. Early investors in the company such as CPH Bank also contributed […]

February 18, 2020 - 2 minutesmins - By Helen Albert

News and Trends 17 Feb 2020

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Oxford-based OMass Therapeutics has extended its Series A round by €33M to fund the spectrometry-assisted development of drugs targeting G protein-coupled receptors. OMass Therapeutics’s Series A initially raised €17M in late 2018. The new funds bring this up to €50M (£41.5M). Investors in the most recent fundraise included the UK VC firm Syncona — which […]

February 17, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2020

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Italian technology transfer company AurorA-TT has joined forces with drug discovery companies Rottapharm Biotech and Italfarmaco to launch the biotech investment enterprise AurorA Science to support early stage biotechs. The partnership plans to invest €1–5M in each of one or two European start-ups this year. It is particularly focusing on promising biotechs in any area […]

February 14, 2020 - 2 minutesmins - By Laura Cowen

novadiscovery in silico clinical trial ai

Startup Scout 14 Feb 2020

Novadiscovery Carries out Clinical Trials using AI and Simulations

Novadiscovery, based in Lyon, France, is developing AI-based simulation technology to predict clinical trial outcomes and cut their running costs. Mission: To predict the outcomes of clinical trials in silico using a combination of artificial intelligence (AI) and computational models of the biology underlying the disease. Clinical trials cost the healthcare industry billions of euros […]

February 14, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Feb 2020

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

The Danish industrial biotech company Novozymes has announced the launch of its latest non-GM yeast technology, Innova Fit, which it says reduces biofuel production bottlenecks caused by conventional and basic yeast. Biofuels, including ethanol, are a renewable energy source being used as a replacement for fossil fuels, with substantially reduced CO2 emissions, particularly in the transport […]

February 14, 2020 - 3 minutesmins - By External Contributor

News and Trends 13 Feb 2020

French Partnership Deploys AI for Antibody Drug Discovery

French companies OSE Immunotherapeutics and MAbSilico are teaming up to drive the discovery of new antibody drugs using artificial intelligence. The three-year partnership will use artificial intelligence, or AI, in six programs designed to accelerate the development of therapeutic monoclonal antibodies (mAbs) that can target cancer and autoimmune diseases. AI can improve the efficiency of […]

February 13, 2020 - 2 minutesmins - By External Contributor

automation arctoris molecule drug discovery

News and Trends 13 Feb 2020

UK-Swiss Collaboration to Boost Biotech Profits with Automation

A partnership between the UK lab automation company Arctoris and Swiss software firm Molecule aims to make it easier to share drug intellectual property in a time of declining returns in pharma. The pharmaceutical industry is struggling with the rising costs of developing new drugs. In fact, the return on investment for drug discovery is […]

February 13, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 12 Feb 2020

Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics

Ingestible pellets containing a charcoal-like treatment — designed by the French company Da Volterra — can stop the microbiome from being disrupted in hospitalized patients treated with antibiotics. The treatment also showed the potential to reduce the risk of Clostridium difficile gut infections in a phase II trial. When patients are given antibiotics for infections, […]

February 12, 2020 - 2 minutesmins - By Jonathan Smith

Interview 12 Feb 2020

Boosting Cancer Research by Unlocking Genomic Data

More genomic data is produced today than ever before as it’s fundamental to the development of new medicines. But although there is a lot of data out there, much of it is inaccessible. With a background in computer science and bioinformatics, Fiona Nielsen, co-founder and CEO of Repositive, decided to overcome this bottleneck and open […]

February 12, 2020 - 6 minutesmins - By Larissa Warneck-Silvestrin

stilla technologies pcr molecular diagnostics

News and Trends 11 Feb 2020

French Biotech Raises €20M to Make Precision Molecular Diagnostics

Stilla Technologies has raised a €20M Series C round to fund its mission to produce next-generation microchips that make molecular diagnostics more precise and user-friendly than currently available lab technology. Contributors to the round included Stilla’s existing investors, such as Illumina Ventures, Kurma Partners and Idinvest Partners. Stilla also added the Chinese company TUS-Holdings to […]

February 11, 2020 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Immatics Partners GSK in Deal Worth €1B to Develop Cancer Therapies

Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper

OncoDNA Secures €19M to Progress Precision Cancer Treatment Technology

UK Biotech Closes €50M Series A for GPCR Drug Discovery

Italian Investment Firm AurorA Science Launches to Support Early Stage Biotechs

Novadiscovery Carries out Clinical Trials using AI and Simulations

Novozymes Launches Super Robust Yeast to Maximize Biofuel Production

French Partnership Deploys AI for Antibody Drug Discovery

UK-Swiss Collaboration to Boost Biotech Profits with Automation

Charcoal-Based Treatment Can Protect Gut Microbiome from Antibiotics

Boosting Cancer Research by Unlocking Genomic Data

French Biotech Raises €20M to Make Precision Molecular Diagnostics

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!